Literature DB >> 16445073

An innovation in drug prevention programs for adolescents: the Hong Kong Astro project.

Chiu Wan Lam1, Daniel T L Shek, Ho Yee Ng, Ka Ching Yeung, Debbie O B Lam.   

Abstract

UNLABELLED: Recent approaches to drug prevention have turned to focus on comprehensive strategies that target early risk factors and that strengthen protective factors in adolescence.
OBJECTIVE: To develop a drug prevention program that is evidence-based and conceptually sound for the Chinese community. STUDY GROUP: The "Astro" project was designed for high-risk youths in Hong Kong and consisted of three psychosocial primary prevention programs conducted in structured group sessions.
METHODS: A three-year longitudinal study and control group comparisons are integrated in this project for the program evaluation. RESULTS AND
CONCLUSIONS: The findings showed that the experimental group, after participating in the programs, was generally better than the control group in terms of social skills, knowledge of drugs, refusal skills, attitudes towards drugs, and the behavioral intention to avoid drug abuse. It suggests that this program could function well as a drug prevention program.

Entities:  

Mesh:

Year:  2005        PMID: 16445073     DOI: 10.1515/ijamh.2005.17.4.343

Source DB:  PubMed          Journal:  Int J Adolesc Med Health        ISSN: 0334-0139


  3 in total

1.  Longitudinal impact of the project PATHS on adolescent risk behavior: what happened after five years?

Authors:  Daniel T L Shek; Lu Yu
Journal:  ScientificWorldJournal       Date:  2012-01-29

2.  Outcome Evaluation of a Short-Term Hospitalization and Community Support Program for People Who Abuse Ketamine.

Authors:  Andrew M H Siu; Flora S L Ko; S K Mak
Journal:  Front Psychiatry       Date:  2018-07-17       Impact factor: 4.157

3.  Evaluation of the effectiveness of a positive youth development program for secondary students in Macau.

Authors:  Andrew L Luk; K M Leong; Annah M L Au
Journal:  ScientificWorldJournal       Date:  2012-07-31
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.